Renaissance Technologies
VMD icon

Renaissance Technologies’s Viemed Healthcare VMD Stock Holding History

Renaissance Technologies’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.86M Sell
425,900
-16,300
-4% -$161K 0.01% 1484
2026
Q1 		$4.07M Buy
442,200
+1,400
+0.3% +$11.7K 0.01% 1486
2025
Q4 		$3.28M Sell
440,800
-6,200
-1% -$42.5K 0.01% 1588
2025
Q3 		$3.04M Buy
447,000
+36,700
+9% +$248K ﹤0.01% 1785
2025
Q2 		$2.84M Buy
410,300
+25,900
+7% +$176K ﹤0.01% 1893
2025
Q1 		$2.8M Buy
384,400
+11,400
+3% +$89.5K ﹤0.01% 1788
2024
Q4 		$2.99M Buy
373,000
+8,400
+2% +$72.9K ﹤0.01% 1781
2024
Q3 		$2.67M Sell
364,600
-74,100
-17% -$529K ﹤0.01% 1835
2024
Q2 		$2.87M Buy
438,700
+147,900
+51% +$1.11M ﹤0.01% 1646
2024
Q1 		$2.74M Buy
290,800
+6,800
+2% +$58.3K ﹤0.01% 1816
2023
Q4 		$2.23M Sell
284,000
-42,700
-13% -$310K ﹤0.01% 1882
2023
Q3 		$2.2M Buy
326,700
+82,400
+34% +$675K ﹤0.01% 1803
2023
Q2 		$2.39M Buy
244,300
+68,900
+39% +$700K ﹤0.01% 1878
2023
Q1 		$1.69M Buy
175,400
+300
+0.2% +$2.62K ﹤0.01% 2132
2022
Q4 		$1.32M Sell
175,100
-89,300
-34% -$605K ﹤0.01% 2364
2022
Q3 		$1.59M Buy
264,400
+5,500
+2% +$35.3K ﹤0.01% 2186
2022
Q2 		$1.39M Sell
258,900
-95,756
-27% -$516K ﹤0.01% 2477
2022
Q1 		$1.77M Buy
354,656
+186,256
+111% +$865K ﹤0.01% 2319
2021
Q4 		$879K Sell
168,400
-285,400
-63% -$1.59M ﹤0.01% 2745
2021
Q3 		$2.52M Buy
453,800
+32,000
+8% +$208K ﹤0.01% 1915
2021
Q2 		$3.02M Buy
421,800
+105,198
+33% +$911K ﹤0.01% 1968
2021
Q1 		$3.21M Buy
316,602
+234,002
+283% +$2.2M ﹤0.01% 1922
2020
Q4 		$641K Buy
82,600
+68,900
+503% +$606K ﹤0.01% 2717
2020
Q3 		$118K Sell
13,700
-48,500
-78% -$489K ﹤0.01% 3193
2020
Q2 		$597K Buy
62,200
+41,700
+203% +$324K ﹤0.01% 2807
2020
Q1 		$98K Sell
20,500
-166,900
-89% -$828K ﹤0.01% 3234
2019
Q4 		$1.17M Buy
187,400
+174,300
+1,331% +$1.21M ﹤0.01% 2554
2019
Q3 		$90K Buy
+13,100
New +$87.3K ﹤0.01% 3270

Other funds holding VMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3B AUM 119.43% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Renaissance Technologies's VMD Position: Q2 2026 in Review

Renaissance Technologies reduced its Viemed Healthcare (VMD) stake by 3.7% in Q2 2026, selling an estimated $161K and leaving 425,900 shares worth $4.86M. The position accounts for 0.01% of the portfolio, ranked #1484.

Renaissance Technologies first reported a position in VMD in Q3 2019 and has held it in 28 quarters since. 156 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • Renaissance Technologies held 425,900 shares of Viemed Healthcare worth $4.86M as of Q2 2026.
  • Renaissance Technologies sold 16,300 Viemed Healthcare shares in Q2 2026, an estimated $161K.
  • Viemed Healthcare made up 0.01% of Renaissance Technologies's portfolio in Q2 2026, its #1484 holding.
  • Renaissance Technologies first reported a position in Viemed Healthcare in Q3 2019 and has held it in 28 quarters since.
  • 156 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.